IRON

Disc Medicine (IRON)

Disc Medicine Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	21 : 00	GlobeNewswire Inc.	Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference	NASDAQ:IRON	Disc Medicine Inc
2024/05/09	21 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IRON	Disc Medicine Inc
2024/05/09	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/05/09	21 : 00	GlobeNewswire Inc.	Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
2024/04/01	21 : 00	GlobeNewswire Inc.	Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)	NASDAQ:IRON	Disc Medicine Inc
2024/03/21	21 : 00	GlobeNewswire Inc.	Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
2024/03/07	06 : 30	GlobeNewswire Inc.	Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/03/02	09 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/02/26	22 : 43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/02/26	22 : 30	GlobeNewswire Inc.	Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer	NASDAQ:IRON	Disc Medicine Inc
2024/02/20	22 : 30	GlobeNewswire Inc.	Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease	NASDAQ:IRON	Disc Medicine Inc
2024/02/16	06 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/02/14	08 : 51	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IRON	Disc Medicine Inc
2024/02/09	23 : 00	GlobeNewswire Inc.	Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera	NASDAQ:IRON	Disc Medicine Inc
2024/02/07	22 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/02/07	22 : 00	GlobeNewswire Inc.	Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer	NASDAQ:IRON	Disc Medicine Inc
2024/02/07	06 : 55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/24	07 : 48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/05	06 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/04	07 : 00	GlobeNewswire Inc.	Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:IRON	Disc Medicine Inc
2024/01/04	06 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/01/03	06 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/30	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/21	06 : 30	GlobeNewswire Inc.	Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board	NASDAQ:IRON	Disc Medicine Inc
2023/12/15	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/13	06 : 19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2023/12/12	10 : 30	GlobeNewswire Inc.	Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc